AstraZeneca's Risky Bet On Drug Discovery

摘要

During a meal of beef and potatoes at AstraZeneca's drug research center near Stockholm in October, Chief Executive Officer David Brennan grilled six drug development managers over a concern raised by a laboratory scientist. During a town hall meeting that morning, the newly recruited researcher had told Brennan he didn't have the freedom to pursue unusual ideas that he would have in academia, and Brennan wanted to know why, according to one research manager who was questioned by the boss. Brennan has more reason than most drug company CEOs to want his scientists to be happy and productive.